ED
Elizabeth Douville
Life sciences executive
ED
Elizabeth Douville
Life sciences executive
Montreal, Quebec
Overview
Elizabeth Douville is a life sciences executive based in Montreal, Quebec, with a strong background in biotechnology, technology transfer, venture capital, and commercialization. She has served as the President & CEO of IRICoR and founded AmorChem, while also holding board positions at various prominent organizations such as Genome Canada and BioCanRx.
Douville has successfully led IRICoR and founded AmorChem, demonstrating a track record of driving innovation and commercialization in the life sciences industry. She has also made strategic investments in companies like Inversago Pharma and Semathera, contributing to their growth and success.
Work Experience
Board Member
2024 - Current
President & CEO
2023
Founder
2011
AmorChem is a leading early-stage venture capital investing in research innovation and creating next-gen biotech companies in life sciences. The fund has 95M$ under management for pre-seed, seed and Series A investments.
Chair
2019
Board Member
2016 - 2019
Board Member
2017
Corbin Therapeutics develops USP15 inhibitors to treat and manage neuroinflamation.
Member
2016
Board Member
2020
SemaThera develops anti-SEMA3A biologics to treat diabetic macular edema.
Board Observer
2018 - 2020
Board Observer
2018 - 2022
Inversago Pharma develops next gen CB1 inverse agonists to treat Prader-Willi Syndrome
Board Member
2015 - 2020
Board Member
2013 - 2018
Education
ICD-Rotman, Directors Education Program
2022 - 2023
CIREM-HEC Certificate
2008 - 2008
PhD
1989 - 1994
Postdoctoral internship
1994 - 1997
Bachelor
1984 - 1987